Section Arrow
XENE.NASDAQ
- Xenon Pharmaceuticals
Quotes are at least 15-min delayed:2025/06/02 11:57 EDT
Last
 29.67
+0.82 (+2.84%)
Day High 
30.37 
Prev. Close
28.85 
1-M High
39.01 
Volume 
293.57K 
Bid
29.65
Ask
29.69
Day Low
28.97 
Open
29.11 
1-M Low
28.19 
Market Cap 
2.21B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 29.92 
20-SMA 32.04 
50-SMA 33.34 
52-W High 46 
52-W Low 26.74 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.22/-4.81
Enterprise Value
2.22B
Balance Sheet
Book Value Per Share
9.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OGENOragenics0.2102+0.0902+75.17%-- 
IRDOpus Genetics Inc1.275+0.2805+28.21%-- 
BPMCBlueprint Medicines Corp127.815+26.465+26.11%-- 
LYRALyra Therapeutics Inc25.51+20.58+417.44%-- 
PSTVPlus Therapeutics0.3217+0.0348+12.13%-- 
Quotes are at least 15-min delayed:2025/06/02 11:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.